C114H108Br2ClF14N31O9S2 — CID 167619514
2-(1H-benzimidazol-2-yl)-4-[2-(1-methylsulfonylpiperidin-4-yl)ethyl]-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one;bis(2-(6-bromo-1H-benzimidazol-2-yl)-4-(2-piperidin-4-ylethyl)-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one);2-(6-chloro-1H-benzimidazol-2-yl)-5-(1-methylsulfonylpiperidin-4-yl)-4-[2-(triazol-2-yl)ethyl]-1H-pyrazol-3-one;2-(6-fluoro-1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one (PubChem CID 167619514) has the molecular formula C114H108Br2ClF14N31O9S2 and a molecular weight of 2581.69 g/mol. Its IUPAC name is 2-(1H-benzimidazol-2-yl)-4-[2-(1-methylsulfonylpiperidin-4-yl)ethyl]-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one;bis(2-(6-bromo-1H-benzimidazol-2-yl)-4-(2-piperidin-4-ylethyl)-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one);2-(6-chloro-1H-benzimidazol-2-yl)-5-(1-methylsulfonylpiperidin-4-yl)-4-[2-(triazol-2-yl)ethyl]-1H-pyrazol-3-one;2-(6-fluoro-1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one.
| Compound Name | 2-(1H-benzimidazol-2-yl)-4-[2-(1-methylsulfonylpiperidin-4-yl)ethyl]-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one;bis(2-(6-bromo-1H-benzimidazol-2-yl)-4-(2-piperidin-4-ylethyl)-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one);2-(6-chloro-1H-benzimidazol-2-yl)-5-(1-methylsulfonylpiperidin-4-yl)-4-[2-(triazol-2-yl)ethyl]-1H-pyrazol-3-one;2-(6-fluoro-1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one |
|---|---|
| PubChem CID | 167619514 |
| Molecular Formula | C114H108Br2ClF14N31O9S2 |
| Molecular Weight | 2581.69 g/mol |
| Exact Mass | 2577.62 |
| IUPAC Name | 2-(1H-benzimidazol-2-yl)-4-[2-(1-methylsulfonylpiperidin-4-yl)ethyl]-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one;bis(2-(6-bromo-1H-benzimidazol-2-yl)-4-(2-piperidin-4-ylethyl)-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one);2-(6-chloro-1H-benzimidazol-2-yl)-5-(1-methylsulfonylpiperidin-4-yl)-4-[2-(triazol-2-yl)ethyl]-1H-pyrazol-3-one;2-(6-fluoro-1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-3-one |
| SMILES | CS(=O)(=O)N1CCC(CCc2c(-c3ccc(C(F)(F)F)cn3)[nH]n(-c3nc4ccccc4[nH]3)c2=O)CC1.CS(=O)(=O)N1CCC(c2[nH]n(-c3nc4ccc(Cl)cc4[nH]3)c(=O)c2CCn2nccn2)CC1.O=c1c(CCC2CCNCC2)c(-c2ccc(C(F)(F)F)cn2)[nH]n1-c1nc2ccc(Br)cc2[nH]1.O=c1c(CCC2CCNCC2)c(-c2ccc(C(F)(F)F)cn2)[nH]n1-c1nc2ccc(Br)cc2[nH]1.O=c1c(CCc2ccc(F)cc2)c(-c2ccc(C(F)(F)F)cn2)[nH]n1-c1nc2ccc(F)cc2[nH]1 |
| InChI | InChI=1S/C24H16F5N5O.C24H25F3N6O3S.2C23H22BrF3N6O.C20H23ClN8O3S/c25-15-5-1-13(2-6-15)3-8-17-21(19-9-4-14(12-30-19)24(27,28)29)33-34(22(17)35)23-31-18-10-7-16(26)11-20(18)32-23;1-37(35,36)32-12-10-15(11-13-32)6-8-17-21(20-9-7-16(14-28-20)24(25,26)27)31-33(22(17)34)23-29-18-4-2-3-5-19(18)30-23;2*24-15-3-6-17-19(11-15)31-22(30-17)33-21(34)16(4-1-13-7-9-28-10-8-13)20(32-33)18-5-2-14(12-29-18)23(25,26)27;1-33(31,32)27-9-4-13(5-10-27)18-15(6-11-28-22-7-8-23-28)19(30)29(26-18)20-24-16-3-2-14(21)12-17(16)25-20/h1-2,4-7,9-12,33H,3,8H2,(H,31,32);2-5,7,9,14-15,31H,6,8,10-13H2,1H3,(H,29,30);2*2-3,5-6,11-13,28,32H,1,4,7-10H2,(H,30,31);2-3,7-8,12-13,26H,4-6,9-11H2,1H3,(H,24,25) |
| InChIKey | TYFYLJIRLDJBCS-UHFFFAOYSA-N |
| XLogP | 20.22 |
| TPSA | 513.44 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 173 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2581.69 |
| LogP ≤ 5 | 20.22 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 28 |